Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELLA: Cilostazol in Vasospastic Angina
NCT01444885Phase 2Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cilostazol in vasospastic angina (VSA), sponsored by Otsuka Holdings. Started Oct 2011; status: completed.
02
Drugs
cilostazol
03
Conditions
vasospastic angina (VSA)
Beyond the preview
Go deeper on NCT01444885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01444885.